Treatment of central serous chorioretinopathy by beta-blocking agents;Léčba centrální serózní chorioretinopatie betablokátory

Ceska a Slovenska Oftalmologie

Volumn 58, Issue 6, 2002, Pages 382-386

  Chrapek, O ^a   Spackova K ^a   Rehak J ^a  

^a NONE

Author keywords

Beta blockers; Central serous chorioretinopathy

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METIPRANOLOL;

ARTICLE; CENTRAL SEROUS RETINOPATHY; CLINICAL ARTICLE; DRUG EFFICACY; HUMAN; NEUROEPITHELIUM; REMISSION; RETINA MACULA LUTEA; TREATMENT FAILURE; ADULT; CHOROID DISEASE; FEMALE; MALE; PATHOPHYSIOLOGY; RETINA DISEASE; VISUAL ACUITY;

ADRENERGIC BETA-ANTAGONISTS; ADULT; CHOROID DISEASES; FEMALE; HUMANS; MALE; METIPRANOLOL; RETINAL DISEASES; VISUAL ACUITY;

EID: 0036939744     PISSN: 12119059     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Avci, R., Deutman, A. F.: Die Behandlung der zentrallen serösen Choroidopathie mit dem Betarezeptorenblocker Metoprolol. Klin. Monatsbl. Augenheilkd., 202, 1993, s. 199-205.
2. Dellaporta, A.: Central serous retinopathy. Trans. Am. Ophthalmol. Soc., 74, 1976, s. 144-151.
3. Fabianová, J., Porubská, M., Čepilová, Z.: Centrálna serózna chorioretinopatia - liečba betablokátormi. Čs. Oftal., 54, 1998, s. 401-404.
4. Fabianová, J., Porubská, M., Čepilová, Z.: Centrálna serózna chorioretinopatia - nový model etiopatogenézy. Čs. Oftal., 54, 1998, s. 405-408.
5. Harada, T., Harada, K.: Six cases of central serous choroidopathy induced by systemic corticosteroid therapy. Doc. Ophthalmol., 60, 1985, s. 37-44.
6. Klein, M., Buskirk, A.M., Friedman, E. et al.: Experience with non treatment of central serous choroidopathy. Arch. Ophthalmol., 91, 1974, s. 247-250.
7. Koh, S. W. M., Chader, G. J.: Retinal pigment epithelium in culture demostrates a distinct beta-adrenergic receptor. Exp. Eye Res., 38, 1984, s. 7-13.
8. Kondrová, J.: Centrálni serózni chorioretinopatie. Čs. Oftal., 51, 1995, s. 304-309.
9. Miki, T., Sunada, I., Hagaki, T.: Studies on chorioretinitis induced in rabbits by stress (Repeated administration of epinefrine). Acta Soc. Ophthalmol. Jpn., 76, 1972, s. 1057-1045.
10. Mitchell, G. C., Owens, S. L., Smith, P. D. et al.: Long term follow-up of central serous choroidopathy. Br. J. Ophthalmol., 68, 1984, s. 815-820.
11. Nagayoski, K.: Experimental study of chorioretinopathy by intravenous injection of adrenaline. Acta Soc. Ophthalmol. Jpn., 75, 1971, s. 1720-1727.
12. Nanjiani, M.: Long term follow-up of central serous retinopathy. Trans. Ophthalmol. Soc. UK, 97, 1977, s. 656-661.
13. Nordholm, I.: Central serous retinitis. A follow-up study. Acta Ophthalmol., 47, 1969, s. 890-898.
14. Potts, A. M.: An hypothesis on macular disease. Trans. Am. Acad. Ophthalmol. Otolaryngol., 70, 1966, s. 1058-1062.
15. Robertson, D., Ilstrup, D.: Direct, indirect, and sham laser photocoagulation in the management of central serous retinopathy: a new working hypothesis. Graefe Arch. Clin. Exp. Ophthalmol., 224, 1986, s. 321-324.
16. Spitzmans, M.: Pathogenesis of central serous retinopathy: a new working hypothesis. Graefe Arch. Clin. Exp. Ophthalmol., 224, 1986, s. 321-324.
17. Theodossiadis, G., Tongos, D.: Treatment of central serous retinopathy: A comparative study with and without light coagulation. Ophthalmologica, 169, 1974, s. 416-431.
18. Yannuzzi, L. A.: Type-A behaviour and central serous chorioretinopathy. Retina, 7, 1987, s. 111-130.
19. Yasuzumi, T., Miki, T., Sugimoto, K.: Electron microscopic studies of epinefrine choroiditis in rabbits. I. pigment epithelium and Bruch's membrane in the healed stage. Acta Soc. Ophthalmol. Jpn., 78, 1974, s. 588-598.